Mesuron Avalon-H90 MCG Device Magnetocardiography Utility Measurement in Cardiac Catheterization

Overview

About this study

The purpose of this study is to measure the utility of Magnetocardiography (MCG) using the Mesuron Avalon-H90 MCG device in discerning underlying myocardial disease in patients presenting to the Catheterization Laboratory for coronary angiography, hemodynamic studies, or myocardial biopsy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients presenting to the catheterization laboratory to undergo non-emergent cardiac catheterization procedures including coronary angiography, percutaneous coronary intervention, right heart cath, ablation, myocardial biopsy.
Adult patients (18 years old or older).
Patient willing and able to give informed consent.

Exclusion Criteria:

Emergent procedure.
ST elevation > 1 mm on any two contiguous ECG leads.
Hemodynamic instability (SBP > 220 or < 80, HR > 160).
Patients < 18 years old (children).
Patients known or suspected to be pregnant.
Incarcerated patients (FMC patients).
Patients with a pacemaker or defibrillator.
Metal implants in the body (that are not MRI safe).
Patients that are unable to lie down in the MCG machine or stay still.
Patients who are unable to understand the informed consent process (ex: non-English speakers without an available interpreter, cognitive delay).
Patients without the capacity to provide written informed consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/17/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Mohamad Adnan Alkhouli, M.D.	Open for enrollment	Contact information: Mohamad Adnan Alkhouli M.D. (507) 255-3504 Alkhouli.Mohamad@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mohamad Adnan Alkhouli, M.D.

Open for enrollment

Contact information:

Mohamad Adnan Alkhouli M.D.

(507) 255-3504

Alkhouli.Mohamad@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials